BREAKING NEWS

U.S. health regulator approves Teva's migraine drug

By REUTERS

SEPTEMBER 15, 2018 01:29

Israeli drugmaker Teva Pharmaceutical Industries on Friday received approval from the U.S. Food and Drug Administration to sell its new migraine treatment, a key drug the company has been banking on to help revive its fortunes.

The world's largest generic drugmaker had hoped to receive approval for the injectable drug, fremanezumab, by June. Its release was delayed due to U.S. regulatory concerns about the manufacturing process at the South Korean plant of its development partner Celltrion.

Around 39 million Americans suffer from migraine headaches, according to the Migraine Research Foundation, making for a large market that has attracted several drugmakers.

12 soldiers stung by hornets in southern Gaza Strip

By JERUSALEM POST STAFF

05/10/2024 01:58 PM

UKMTO receives a report of an incident 195 nm east of Yemen's Aden

By REUTERS

05/10/2024 09:31 AM

Blinken expected to submit highly critical Israel report to congress

By JERUSALEM POST STAFF

05/10/2024 08:14 AM

Man shoots and wounds two police officers in Paris, French media reports

By REUTERS

05/10/2024 12:49 AM